Striving to Quit: First Breath (STQ FB)
Striving to Quit: First Breath Tobacco Cessation Research
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Aim 1: To determine the extent to which contingent financial "treatment incentives" (i.e., incentives for biochemical verification visits, treatment engagement, and abstinence) versus "attendance incentives" (i.e., incentives for only attending the biochemical verification visits), increase rates of prenatal and postnatal smoking abstinence. Participants will be BadgerCare Plus members who are recruited into the First Breath program while pregnant.
Aim 2: To determine the extent to which treatment incentives, versus attendance incentives, increase rates of engagement in First Breath smoking cessation intervention when offered to pregnant and postpartum BadgerCare Plus members.
Aim 3: To determine the cost-effectiveness and reach of the First Breath intervention delivered to pregnant and postpartum smokers when it is paired with treatment incentives and when paired with only attendance incentives.
Aim 4: To determine if the First Breath intervention with treatment incentives, in comparison to that intervention with only attendance incentives, produces significantly greater benefits in pregnant and postpartum women with regards to nonsmoking health outcomes: i.e., reduced depression, increased levels of breast feeding, and greater perceived support.
Aim 5: To identify moderating and mediating effects of treatment incentives when offered in the context of the First Breath intervention delivered to pregnant and postpartum women.
Type d'étude
Inscription (Anticipé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Wisconsin
-
Madison, Wisconsin, États-Unis, 53713
- Wisconsin Women's Health Foundation
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- pregnant women
- enrollment in Wisconsin Medicaid (BadgerCare Plus or Medicaid SSI)
- resides in study area
- member of participating Medicaid HMOs
- not involved in any other stop smoking research studies
- 18 or older
- English speaking
- smoked daily (at least one cigarette each day for at least one week) at some time within the last 6 months
- willingness to quit smoking, cut down, or stay quit
- willing to complete study visits and phone calls
- willing to provide updates in contact information
Exclusion Criteria:
- not enrolled in Wisconsin Medicaid (BadgerCare Plus or Medicaid SSI)
- not enrolled in study area
- not a member of participating Medicaid HMOs
- not pregnant or enrolled in First Breath
- less than 18 years of age
- non-English speaking
- does not smoke daily (at least one cigarette each day for at least one week) at least some time within the last 6 months
- not willing to complete study procedures and assessments or provide updated contact information
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Treatment incentives
Incentives for biochemical verification visits, treatment engagement, and abstinence
|
Treatment Incentives - incentives for biochemical verification visits, treatment engagement, and abstinence
|
|
Comparateur actif: Attendance incentive
Incentives for only attending the biochemical verification visits
|
Attendance Incentives - incentives for only attending the biochemical verification visits
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Abstinence from smoking
Délai: Measured 6 months after births at follow-up assessment
|
The data will be the biochemically confirmed reports of abstinence for the past 7 days (i.e., 7-day point-prevalence abstinence)
|
Measured 6 months after births at follow-up assessment
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Engagement in treatment
Délai: Measured 12 months after birth at follow-up assessment
|
The primary analyses will compare number of calls and visits completed.
|
Measured 12 months after birth at follow-up assessment
|
|
Cost-effectiveness
Délai: Measured 12 months after birth
|
The primary analysis will contrast the incremental costs of the treatment vs. attendance conditions by computing the Incremental Cost-Effectiveness Ratio (ICER) with regard to attaining 6-month abstinence.
|
Measured 12 months after birth
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Timothy B. Baker, PhD, University of Wisconsin, Madison
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2012-0136
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .